Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study
Yujia Zhao1, Yunjia Lai2, Sirwan K L Darweesh3
1Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Background:
Alterations in gut microbiota are observed in Parkinson's disease (PD). Previous studies on microbiota-derived metabolites in PD were small-scale and post-diagnosis, raising concerns about reverse causality.
Objectives:
Our goal was to prospectively investigate the association between plasma microbial metabolites and PD risk within a metabolomics framework.
Methods:
A nested case-control study within the prospective EPIC4PD cohort, measured pre-diagnostic plasma microbial metabolites using untargeted metabolomics.
Results:
Thirteen microbial metabolites were identified nominally associated with PD risk (P-value < 0.05), including amino acids, bile acid, indoles, and hydroxy acid, although none remained significant after multiple testing correction. Three pathways were implicated in PD risk: valine, leucine, and isoleucine degradation, butanoate metabolism, and propanoate metabolism. PD-associated microbial pathways were more pronounced in men, smokers, and overweight/obese individuals.
Conclusion:
Changes in microbial metabolites may represent a pre-diagnostic feature of PD. We observed biologically plausible associations between microbial pathways and PD, potentially influenced by individual characteristics. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Insights
Pre-diagnostic plasma microbial metabolites may indicate Parkinson's disease (PD) risk. This study found associations between microbial pathways and PD, particularly in men, smokers, and overweight individuals.
Area of Science:
- Microbiome research
- Neurodegenerative disease
- Metabolomics
Background:
- Gut microbiota alterations are linked to Parkinson's disease (PD).
- Previous studies were limited by small sample sizes and post-diagnosis analysis, raising causality concerns.
Purpose of the Study:
- To prospectively investigate the link between plasma microbial metabolites and PD risk.
- To establish a metabolomics framework for pre-diagnostic PD research.
Main Methods:
- Nested case-control study within the EPIC4PD cohort.
- Untargeted metabolomics to measure pre-diagnostic plasma microbial metabolites.
Main Results:
- Thirteen microbial metabolites showed nominal association with PD risk (P < 0.05), including amino acids, bile acids, indoles, and hydroxy acids.
- Three pathways implicated: valine/leucine/isoleucine degradation, butanoate, and propanoate metabolism.
- Associations were stronger in men, smokers, and overweight/obese individuals.
Conclusions:
- Plasma microbial metabolite changes may precede PD diagnosis.
- Biologically plausible links between microbial pathways and PD risk were identified.
- Individual characteristics may influence these associations.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation

